Breast Cancer Clinical Trial

Move Together Boston Feasibility Pilot (Sit Less, Move More App for Black Breast Cancer Survivors & At-Risk Relatives)

Summary

The purpose of this study is to develop and test a mobile app for Black/African American breast cancer survivors and their relatives, called Move Together, that promotes sitting less and moving more for better health.

View Full Description

Full Description

The purpose of this study is to develop and test a mobile app for Black/African American breast cancer survivors and their relatives, called Move Together, that promotes sitting less and moving more for better health.

This is a cross-sectional descriptive study using structured interviews and qualitative data analysis to develop an intervention, followed by a pilot test of the intervention with pre- /post- measures.

In study phase 1,involved qualitative interviews with 5 community leader key informants, 9 breast cancer survivors and 6 first degree relatives of a survivor.

This part of the research study is a Pilot Study, which means it is the first time that researchers are studying usability and acceptability of the Move Together app.

Participants in the pilot study will participate as members of family-based dyads (n=10 dyads). One member of each dyad will be a breast cancer survivor and one will be a blood relative
Study involves screening for eligibility, interviews, questionnaires, Use of Move Together app with Garmin activity tracker watch
Participation on the trial will be for 5 weeks
About 20 people (10 survivors with 10 relatives) will participate in this part of the study, and a total of 58 people in the whole study.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

1a) Key informants (for interviews)

Members of the community/advisory groups, community health centers, or faith-based network members (e.g., Pink and Black, Faces of Faith).
English speaking adults.

(1b) Breast cancer survivors and relatives (for interviews)

Self-identify as Black or African American
Age 18 and over
English speaking
Female breast cancer survivor status post curative antineoplastic treatment (except ongoing hormonal treatment) with no evidence of disease, OR a first degree blood relative (parent, child, or full sibling), of any gender, of a so defined breast cancer survivor
Self-report ever using a smart phone

(2) Breast cancer survivors and relatives (for user testing/interviews)

Self-identify as Black or African American
Age 18 and over
English speaking
Female breast cancer survivor status post curative antineoplastic treatment (except ongoing hormonal treatment) with no evidence of disease, OR a first degree blood relative (parent, child, or full sibling), of any gender, of a so defined breast cancer survivor
Self-report willing/able to download the app for testing on a smart phone
Self-report willing/able to meet via Zoom for interview

(3) Breast cancer survivors and relatives/"buddies" (for pilot testing)

Self-identify as Black or African American
Age 18 and over
English speaking
Breast cancer survivor status post curative antineoplastic treatment (except ongoing hormonal treatment) with no evidence of disease, OR a blood relative, of any gender, of a so defined breast cancer survivor
Self-report willing/able to participate with a blood relative in survivor relative dyad
Self-report willing/able to download the app for use on a smart phone
Self-report willing/able to meet via Zoom for instructions and interview

Exclusion Criteria:

(1a) Key informants (for interviews)

--None

(1b) Breast cancer survivors and relatives (for interviews)

Requires medically supervised physical activity (Physical Activity Readiness Question for Everyone, PAR-Q+, Question 7)
Pregnant women

(2) Breast cancer survivors and relatives (for user testing/interviews)

Requires medically supervised physical activity (Physical Activity Readiness Question for Everyone, PAR-Q+, Question 7)
Pregnant women

(3) Breast cancer survivors and relatives/"buddies" (for pilot testing)

Meets exclusion criterion of the Modified Physical Activity Readiness Questionnaire (PAR-Q) (modified)
Participated in interviews or user testing in prior phases of the study

Study is for people with:

Breast Cancer

Estimated Enrollment:

10

Study ID:

NCT05011279

Recruitment Status:

Completed

Sponsor:

Dana-Farber Cancer Institute

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There are 3 Locations for this study

See Locations Near You

Dana Farber Cancer Institute
Boston Massachusetts, 02115, United States
University of Massachusetts Boston
Boston Massachusetts, 02125, United States
University of Rochester
Rochester New York, 14627, United States

How clear is this clinincal trial information?

Study is for people with:

Breast Cancer

Estimated Enrollment:

10

Study ID:

NCT05011279

Recruitment Status:

Completed

Sponsor:


Dana-Farber Cancer Institute

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.